Blog

ProFound AI Detection delivers clarity, confidence, and peace of mind. ProFound is clinically proven to improve breast cancer detection and radiologist performance. FDA Cleared. CE Marked. Health Canada Licensed.

At this year’s European Congress of Radiology (ECR 2024) in Vienna, Austria, iCAD demonstrated how the ProFound AI Breast Health Suite enables medical providers to detect cancer earlier and more accurately, improving patient outcomes. The demonstrations highlighted the new release of its AI-powered ProFound Detection workflow solution, while showcasing its...

Throughout history, women have played a crucial role in the advancement of radiology and breast imaging, breaking barriers and setting new imaging and safety standards. As we recognize Women’s History Month, this article highlights just a few of the pioneering women whose contributions have been instrumental in shaping the fields...

An AI solution needs to exceed a baseline standard of functionality to be considered. It’s important how the algorithm is trained, validated, and in compliance with world-wide regulations. Ask about features for early detection, density assessment, and near-term image-based breast cancer risk evaluation (in the next one or two years)...

Moving from Computer-Aided Detection (CAD) to AI-powered mammography represents a significant technological advancement in breast imaging. CAD systems, introduced in the late 1990s, were designed to highlight areas of interest on mammograms that radiologists would then review for potential abnormalities. CAD programs weren’t nearly as sensitive or accurate as today’s...

Breast cancer remains a significant health concern globally, and as imaging centers strive to deliver the highest standard of care, incorporating AI into mammography workflows, emerges as a game-changing solution. This article explores the crucial business needs imaging centers face, compelling them to consider the adoption of cutting-edge AI technology...

Attendees at this year’s Radiological Society of North America (RSNA) 2023 Annual Meeting witnessed iCAD’s prominent presence, showcasing groundbreaking advancements in the field of breast imaging and artificial intelligence (AI).  iCAD, a global medical technology leader in innovative cancer detection solutions, made headlines with new clinical data, shared exciting partnership...

Every October, we shine a spotlight on breast cancer during National Breast Cancer Awareness Month. Thanks to the remarkable innovations in AI (Artificial Intelligence), we have more reasons to raise awareness about advancements in mammography than ever before. AI-powered mammography is revolutionizing care for patients’ breast health by finding cancers...

At iCAD, we are recognizing the 2nd annual World Dense Breast Day today, a day that holds significant importance, not only for the women who may have dense breasts but for all of us dedicated to advancing breast health awareness and early cancer detection. As we gather to mark this...